|
Volumn 146, Issue 4, 1992, Pages 473-481
|
How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CANADA;
HEALTH ECONOMICS;
MEDICAL SERVICE;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
TECHNOLOGY;
ARTICLE;
BIOMEDICAL TECHNOLOGY ASSESSMENT;
CLASSIFICATION;
COST;
COST BENEFIT ANALYSIS;
ECONOMICS;
MASS COMMUNICATION;
MEDICAL ETHICS;
MEDICAL TECHNOLOGY;
POLITICS;
QUALITY OF LIFE;
SOCIOECONOMICS;
STANDARD;
TREATMENT OUTCOME;
CANADA;
COST-BENEFIT ANALYSIS;
COSTS AND COST ANALYSIS;
DIFFUSION OF INNOVATION;
ECONOMICS;
ETHICS, MEDICAL;
POLITICS;
QUALITY OF LIFE;
SUPPORT, NON-U.S. GOV'T;
TECHNOLOGY ASSESSMENT, BIOMEDICAL;
TECHNOLOGY, MEDICAL;
TREATMENT OUTCOME;
VALUE OF LIFE;
|
EID: 0026575912
PISSN: 08203946
EISSN: 14882329
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1468)
|
References (0)
|